Literature DB >> 31512624

Endoscopic versus Microscopic Pituitary Adenoma Surgery: A Single-center Study.

Ajler Pablo1, Beltrame Sofia1, Toscano Maximiliano1, Fainstein Day Patricia2, Campero Alvaro3, Yampolsky Claudio1, Carrizo Antonio1.   

Abstract

BACKGROUND: Transsphenoidal approach became the gold standard in the surgical treatment of pituitary adenomas in the past years, but the comparative efficacy of microscopic and endoscopic transnasal surgery has not been fully studied. AIMS: To compare the microscopic and endoscopic transnasal approaches for the treatment of pituitary adenomas. SETTINGS AND
DESIGN: A retrospective analysis was performed, comparing adult patients with pituitary adenomas who had undergone transnasal microscopic surgery between January 2006 and December 2014 with the patients operated on with endoscopic surgery between March 2011 and December 2014 at Hospital Italiano de Buenos Aires.
MATERIAL AND METHODS: Imaging, hormonal, and ophthalmological studies as well as complications were analyzed. STATISTICAL ANALYSIS: Due to the existence of dichotomous variables, Fisher's exact test was used for statistical analysis.
RESULTS: In all, 259 patients who had undergone microsurgery and 140 patients operated on with endoscopy were included. The pathologies compared were microsurgically resected nonfunctioning adenomas: 38.2% (n = 99) versus endoscopically resected: 42.1% (n = 59), and microsurgically resected functioning adenomas: 61.8% (n = 160) versus endoscopically resected: 57.9% (n = 81). A higher number of patients with invasive macroadenomas were reported in the group operated on with endoscopy (35.5% vs. 56.4%). When the patients with invasive pathology of the cavernous sinus were compared, percentages of total resection and hormonal control were higher for endoscopic surgeries (35% vs. 46.8%; 33.3% vs. 64%); however, this difference was not statistically significant. No statistically significant differences were found when postoperative complications were individually analyzed.
CONCLUSION: The microsurgical and endoscopic approaches are safe and effective techniques to treat pituitary adenomas. For invasive adenomas, the endoscopic approach may report better results.

Entities:  

Keywords:  Endoscopic; microscopic; pituitary adenoma; transnasal approach

Mesh:

Year:  2019        PMID: 31512624     DOI: 10.4103/0028-3886.266241

Source DB:  PubMed          Journal:  Neurol India        ISSN: 0028-3886            Impact factor:   2.117


  6 in total

1.  Endoscopic vs. microscopic transsphenoidal surgery outcomes in 514 nonfunctioning pituitary adenoma cases.

Authors:  Shuaihua Song; Linping Wang; Qianjin Qi; Haoran Wang; Li Feng
Journal:  Neurosurg Rev       Date:  2022-03-01       Impact factor: 3.042

2.  Comparison of outcomes between endoscopic and microscopic transsphenoidal surgery for the treatment of pituitary adenoma: a meta-analysis.

Authors:  Xiaolin Chen; Wei Huang; Hongjuan Li; Yan Huan; Guoying Mai; Luming Chen; Hongqiang Huang; Haoxiang Xu
Journal:  Gland Surg       Date:  2020-12

3.  Preliminary Comparison of Transseptal Microscopic Versus Endoscopic Transsphenoidal Surgery in a University Teaching Hospital.

Authors:  Zaitun Zakaria; Zamzuri Idris; Jafri Malin Abdullah; Baharudin Abdullah; Abdul Rahman Izaini Ghani
Journal:  Malays J Med Sci       Date:  2022-02-23

4.  Endoscopic vs. Microscopic Transsphenoidal Surgery for the Treatment of Pituitary Adenoma: A Meta-Analysis.

Authors:  Jia Chen; Hongyan Liu; Siliang Man; Geng Liu; Quan Li; Qingyao Zuo; Lili Huo; Wei Li; Wei Deng
Journal:  Front Surg       Date:  2022-02-02

5.  Analysis of neuroendoscopy for the treatment of macroadenomas and giant pituitary adenomas.

Authors:  Junyong Wu; Binbin Zhang; Dongqi Shao; Shuxin Ji; Yu Li; Shan Xie; Zhiquan Jiang
Journal:  Front Surg       Date:  2022-08-11

6.  Challenges, Learning Curve, and Safety of Endoscopic Endonasal Surgery of Sellar-Suprasellar Lesions in a Community Hospital.

Authors:  Mohamed A R Soliman; Sydney Eaton; Elise Quint; Abdullah F Alkhamees; Saba Shahab; Avalon O'Connor; Erika Haberfellner; Jacob Im; Abdurrahim A Elashaal; Francis Ling; Mustafa Elbreki; Tommy Dang; Dante J Morassutti; Abdalla Shamisa
Journal:  World Neurosurg       Date:  2020-04-13       Impact factor: 2.104

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.